Hong‐Can Ren

407 total citations
18 papers, 331 citations indexed

About

Hong‐Can Ren is a scholar working on Molecular Biology, Pharmacology and Spectroscopy. According to data from OpenAlex, Hong‐Can Ren has authored 18 papers receiving a total of 331 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Pharmacology and 6 papers in Spectroscopy. Recurrent topics in Hong‐Can Ren's work include Metabolomics and Mass Spectrometry Studies (5 papers), Analytical Chemistry and Chromatography (5 papers) and Computational Drug Discovery Methods (4 papers). Hong‐Can Ren is often cited by papers focused on Metabolomics and Mass Spectrometry Studies (5 papers), Analytical Chemistry and Chromatography (5 papers) and Computational Drug Discovery Methods (4 papers). Hong‐Can Ren collaborates with scholars based in China, Belgium and United States. Hong‐Can Ren's co-authors include Guangji Wang, Jiye Aa, Shenghua Gu, Weibin Zha, Bei Yan, Qing Huang, Jianguo Sun, Ying Zhang, Haiping Hao and Longsheng Sheng and has published in prestigious journals such as Analytical Biochemistry, Frontiers in Pharmacology and European Journal of Pharmaceutical Sciences.

In The Last Decade

Hong‐Can Ren

16 papers receiving 322 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hong‐Can Ren China 9 239 68 44 37 33 18 331
Jason H. Winnike United States 11 266 1.1× 54 0.8× 64 1.5× 33 0.9× 89 2.7× 18 430
Wenting Liao China 12 201 0.8× 50 0.7× 15 0.3× 21 0.6× 39 1.2× 31 348
Tianwei Dong China 6 251 1.1× 56 0.8× 39 0.9× 9 0.2× 21 0.6× 10 376
Rie Kikkawa United States 9 125 0.5× 92 1.4× 24 0.5× 24 0.6× 23 0.7× 11 337
Johan Kolmert Sweden 12 242 1.0× 44 0.6× 104 2.4× 18 0.5× 100 3.0× 28 491
Chuncao Xu China 10 169 0.7× 34 0.5× 7 0.2× 32 0.9× 20 0.6× 12 315
Anna Lundahl Sweden 10 83 0.3× 106 1.6× 26 0.6× 101 2.7× 13 0.4× 18 316

Countries citing papers authored by Hong‐Can Ren

Since Specialization
Citations

This map shows the geographic impact of Hong‐Can Ren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hong‐Can Ren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hong‐Can Ren more than expected).

Fields of papers citing papers by Hong‐Can Ren

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hong‐Can Ren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hong‐Can Ren. The network helps show where Hong‐Can Ren may publish in the future.

Co-authorship network of co-authors of Hong‐Can Ren

This figure shows the co-authorship network connecting the top 25 collaborators of Hong‐Can Ren. A scholar is included among the top collaborators of Hong‐Can Ren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hong‐Can Ren. Hong‐Can Ren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
3.
Pin, Jiang, Tao Chen, Qiang Liu, et al.. (2023). Enhancing drug-drug Interaction Prediction by Integrating Physiologically-Based Pharmacokinetic Model with Fraction Metabolized by CYP3A4. Expert Opinion on Drug Metabolism & Toxicology. 19(10). 721–731. 2 indexed citations
4.
Ren, Hong‐Can, Jianguo Sun, Jiye Aa, et al.. (2022). Mechanism-Based Pharmacokinetic Model for the Deglycosylation Kinetics of 20(S)-Ginsenosides Rh2. Frontiers in Pharmacology. 13. 804377–804377. 6 indexed citations
5.
Ren, Hong‐Can, et al.. (2021). Predicting the Drug–Drug Interaction Mediated by CYP3A4 Inhibition: Method Development and Performance Evaluation. The AAPS Journal. 24(1). 12–12. 5 indexed citations
6.
Gu, Yi, Yang Sai, Jian Wang, et al.. (2019). Preclinical pharmacokinetics, disposition, and translational pharmacokinetic/pharmacodynamic modeling of savolitinib, a novel selective cMet inhibitor. European Journal of Pharmaceutical Sciences. 136. 104938–104938. 16 indexed citations
7.
Ren, Hong‐Can, et al.. (2019). Continuous forming of ultrathin glass by float process. International Journal of Applied Glass Science. 10(3). 275–286. 6 indexed citations
8.
Ren, Hong‐Can, Yang Sai, & Tao Chen. (2018). Evaluation of Generic Methods to Predict Human Pharmacokinetics Using Physiologically Based Pharmacokinetic Model for Early Drug Discovery of Tyrosine Kinase Inhibitors. European Journal of Drug Metabolism and Pharmacokinetics. 44(1). 121–132. 6 indexed citations
9.
Gu, Yi, Jian Wang, Ke Li, et al.. (2014). Preclinical pharmacokinetics and disposition of a novel selective VEGFR inhibitor Fruquintinib (HMPL-013) and the prediction of its human pharmacokinetics. Cancer Chemotherapy and Pharmacology. 74(1). 95–115. 40 indexed citations
10.
Gu, Shenghua, Jiye Aa, Guangji Wang, et al.. (2009). Metabonomic profiling of liver metabolites by gas chromatography–mass spectrometry and its application to characterizing hyperlipidemia. Biomedical Chromatography. 24(3). 245–252. 31 indexed citations
11.
Zha, Weibin, Jiye Aa, Guangji Wang, et al.. (2009). Metabonomic characterization of early atherosclerosis in hamsters with induced cholesterol. Biomarkers. 14(6). 372–380. 25 indexed citations
12.
Lai, Li Sze, Yitong Liu, Haiping Hao, et al.. (2009). Determination of 20(S)-Ginsenoside Rh1 and its Aglycone 20(S)-Protopanaxatriol in Rat Plasma by Sensitive LC-APCI-MS Method and its Application to Pharmacokinetic Study. European Journal of Mass Spectrometry. 15(1). 57–65. 7 indexed citations
13.
Zhang, Ying, Jiye Aa, Guangji Wang, et al.. (2009). Organic solvent extraction and metabonomic profiling of the metabolites in erythrocytes. Journal of Chromatography B. 877(18-19). 1751–1757. 21 indexed citations
14.
Aa, Jiye, Guangji Wang, Haiping Hao, et al.. (2008). Gas chromatography/time‐of‐flight mass spectrometry based metabonomic approach to differentiating hypertension‐ and age‐related metabolic variation in spontaneously hypertensive rats. Rapid Communications in Mass Spectrometry. 22(18). 2882–2888. 46 indexed citations
15.
Ren, Hong‐Can, Jianguo Sun, Guangji Wang, et al.. (2008). Sensitive determination of 20(S)-protopanaxadiol in rat plasma using HPLC–APCI-MS: Application of pharmacokinetic study in rats. Journal of Pharmaceutical and Biomedical Analysis. 48(5). 1476–1480. 65 indexed citations
16.
Aa, Jiye, Qing Huang, Guangji Wang, et al.. (2008). Global analysis of metabolites in rat and human urine based on gas chromatography/time-of-flight mass spectrometry. Analytical Biochemistry. 379(1). 20–26. 44 indexed citations
17.
Huang, Qing, Guangji Wang, Jianguo Sun, et al.. (2007). Simultaneous determination of GFA and its active metabolites in human plasma by liquid chromatography electrospray ionization mass spectrometry and its application to pharmacokinetic studies. Journal of Pharmaceutical and Biomedical Analysis. 46(4). 728–736. 8 indexed citations
18.
Zha, Weibin, Jianguo Sun, Guangji Wang, et al.. (2007). LC-ESI-MS Determination of Roxithromycin in Tissues of Beagle Dogs after Multiple Dosing of Roxithromycin Sustained Release Tablets. Chromatographia. 66(7-8). 475–480. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026